WRN Chemical Inc.
Chemical and Intellectual property development services
President attends 92nd Canadian Chemistry Conference and Exhibition in Hamilton, Canada.
President attends 93rd Canadian Chemistry Conference and Exhibition in Toronto, Canada.
WRN Chemical develops new chemical processes for products applicable to the oil, and pharmaceutical industry.
WRN Chemical announces new team members to join accounting and legal departments.
President attends 94th Canadian Chemistry Conference and Exhibition in Montreal, Canada.
President attends FROST 3 conference in Budapest Hungary to discuss partnerships with providers of microreactor technology.
Intellectual property for new pharmaceutical chemical processes is being negotiated for assignment from current inventor.
President attends 243rd Annual American Chemical Society meeting in San Diego, USA.
President secures assignment and licensing rights of intellectual property for green chemical technologies from a Canadian university.
President secures assignment and licensing rights of intellectual property for new chemical process technologies from a Canadian university that can manufacture chemicals used by different industries.
WRN Chemcal licenses new chemical process to a Canadian technology company.
WRN Chemcal strengthens technology portfolio by initiating three patent applications for new pharmaceutical technologies.
WRN Chemical initiates patent application for a new HIV therapeutics technology platform.
WRN Chemical obtains assignment and licensing rights for a new process technology that leads to high value products from a Canadian university.
WRN Chemical welcomes our new legal director to manage technology licensing and other legal activities.
President and CEO of WRN Chemical attends 2014 National Fluids Technical Conference in Houston, Texas and meets with oil and gas producers to discuss new technology opportunities.
WRN Chemical secures licensing rights for a new infectious disease technology portfolio from a Canadian university.